Patient Leaflet Updated 24-Oct-2023 | ADVANZ Pharma
Morphgesic SR 10mg, 30mg, 60mg and 100 mg Tablets
Morphgesic® SR 10 mg, 30 mg, 60 mg and 100 mg Tablets
morphine sulfate
This medicine contains morphine sulfate which is an opioid, which can cause addiction. You can get withdrawal symptoms if you stop taking it suddenly.
1. What Morphgesic SR Tablets are and what they are used for
2. What you need to know before you take Morphgesic SR Tablets
3. How to take Morphgesic SR Tablets
4. Possible side effects
5. How to store Morphgesic SR Tablets
6. Contents of the pack and other information
This medicine has been prescribed for you for prolonged relief from severe pain for up to 12 hours. It contains morphine sulfate which belongs to a class of medicines called opioids, which are ‘pain relievers’. This medicine has been prescribed to you and should not be given to anyone else. Opioids can cause addiction and you may get withdrawal symptoms if you stop taking it suddenly. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.
Tolerance, dependence, and addiction
This medicine contains morphine which is an opioid medicine. Repeated use of opioids can result in the drug being less effective (you become accustomed to it, known as tolerance).
Repeated use of Morphgesic SR Tablets can also lead to dependence, abuse, and addiction, which may result in life-threatening overdose. The risk of these side effects can increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel that you are no longer in control of how much medicine you need to take or how often you need to take it.
The risk of becoming dependent or addicted varies from person to person. You may have a greater risk of becoming dependent on or addicted to Morphgesic SR Tablets if:
If you notice any of the following signs whilst taking Morphgesic SR Tablets, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, speak to your doctor to discuss the best treatment pathway for you, including when it is appropriate to stop and how to stop safely (See section 3, If you stop taking Morphgesic SR Tablets).
Talk to your doctor or pharmacist before taking Morphgesic SR Tablets:
Acute generalized exanthematous pustulosis (AGEP) has been reported in association with Morphgesic SR Tablets treatment. Symptoms usually occur within the first 10 days of treatment. Tell your doctor if you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking Morphgesic SR Tablets or other opioids. Stop using Morphgesic SR Tablets and seek medical attention immediately, if you notice any of the following symptoms: blistering, widespread scaly skin or pus-filled spots together with fever.
Sleep-related breathing disorders
Morphgesic SR Tablets can cause sleep-related breathing disorders such as sleep apnoea (breathing pauses during sleep) and sleep related hypoxemia (low oxygen level in the blood). The symptoms can include breathing pauses during sleep, night awakening due to shortness of breath, difficulties to maintain sleep or excessive drowsiness during the day. If you or another person observe these symptoms, contact your doctor. A dose reduction may be considered by your doctor.
Contact your doctor if you experience severe upper abdominal pain possibly radiating to the back, nausea, vomiting or fever as this could be symptoms associated with inflammation of the pancreas (pancreatitis) and the biliary tract system.
Taking this medicine regularly, particularly for a long time, can lead to addiction. Your prescriber should have explained how long you will be taking it for and when it is appropriate to stop, how to do this safely.
Rarely, increasing the dose of this medicine can make you more sensitive to pain. If this happens, you need to speak to your prescriber about your treatment.
Addiction can cause withdrawal symptoms when you stop taking this medicine. Withdrawal symptoms can include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, loss of appetite, shaking, shivering or sweating. Your prescriber will discuss with you how to gradually reduce your dose before stopping the medicine. It is important that you do not stop taking the medicine suddenly as you will be more likely to experience withdrawal symptoms.
Opioids should only be used by those they are prescribed for. Do not give your medicine to anyone else. Taking higher doses or more frequent doses of opioid, may increase the risk of addiction. Overuse and misuse can lead to overdose and/or death.
If any of these apply to you, or if you are not sure, tell your doctor before taking Morphgesic SR Tablets.
Morphgesic SR Tablets are not recommended for children.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Morphgesic SR Tablets must not be used together with a monoamine oxidase inhibitor, or if you have taken this type of medicine in the last two weeks (see section 'Do not take...').
Examples include tranylcypromide, phenelzine, isocarboxazid, moclobemide and linezolid.
This is especially important if you are taking any of the medicines mentioned below or medicines for:
Morphine may increase the effects of medicines used to control high blood pressure, relax muscles or act as tranquilisers.
Concomitant use of Morphgesic SR Tablets and sedative medicines such as benzodiazepines or related drugs increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor does prescribe Morphgesic SR Tablets together with sedative medicines the dose and duration of concomitant treatment should be limited by your doctor.
Please tell your doctor about all sedative medicines you are taking and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.
Do not drink alcohol while taking Morphgesic SR Tablets, as the tablets can increase the effects of alcohol.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not take Morphgesic SR Tablets if you are pregnant or think you might be pregnant unless you have discussed this with your prescriber and the benefits of treatment are considered to outweigh the potential harm to the baby.
If you use Morphgesic SR Tablets during pregnancy, your baby may become dependent and experience withdrawal symptoms after the birth which may need to be treated.
Breast-feeding
Do not take Morphgesic SR Tablets while you are breastfeeding as morphine sulfate passes into breast milk and will affect your baby.
Morphgesic SR Tablets may cause a number of side effects such as drowsiness, which could affect your ability to drive or use machinery (see section 4 for a full list of side effects). If you are affected you should not drive or use machinery.
The medicine can affect your ability to drive as it may make you sleepy or dizzy.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
Your prescriber should have discussed with you, how long the course of tablets will last. They will arrange a plan for stopping treatment. This will outline how to gradually reduce the dose and stop taking the medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Before starting treatment and regularly during treatment, your doctor will discuss with you what you may expect from using Morphgesic SR Tablets, when and how long you need to take it, when to contact your doctor, and when you need to stop it (see also, If you stop taking Morphgesic SR Tablets, in this section).
The recommended starting dose is one or two 10 mg tablets twice daily. The total daily dose should be taken in two divided doses at 12 hourly intervals. For instance, if you take a tablet at 8 o’clock in the morning, you should take your next tablet at 8 o’clock in the evening.
Swallow your tablets whole with water. Do not crush or chew them.
Your doctor may change your dose depending on your response and how severe your pain is.
Do not take more tablets than the doctor has told you.
Please be aware of the symptoms you may experience from taking too much of your Morphgesic SR medicine. These include extreme drowsiness, pinpoint pupils, confusion, cold and clammy skin, a weak pulse, slowed heart beat, shallow breathing, floppiness or fainting. People who have taken an overdose may get pneumonia from inhaling vomit or foreign matter, symptoms may include breathlessness, cough and fever.
People who have taken an overdose may also have breathing difficulties leading to unconsciousness or even death.
If you have taken too many Morphgesic SR Tablets, contact your doctor or nearest hospital emergency department immediately. Take the container and any remaining tablets with you.
If you forget to take a dose, just take the next dose at the usual time, Do not take a double dose to make up for a forgotten tablet.
Do not suddenly stop taking this medicine. If you want to stop taking this medicine, discuss this with your prescriber first. They will tell you how to do this, usually by reducing the dose gradually so that any unpleasant withdrawal effects are kept to a minimum. Withdrawal symptoms such as restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating may occur if you suddenly stop taking this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines this medicine can cause side effects, although not everybody gets them.
Serious allergic reaction which causes difficulty in breathing or dizziness. All medicines can cause allergic reactions, although serious allergic reactions are uncommon. Tell your doctor immediately if you experience sudden wheeziness, difficulties in breathing or dizziness, swelling of the eyelids, face or lips, rash or itching, especially those covering your whole body.
Morphgesic SR Tablets use may result in coma
Stop using Morphgesic SR Tablets and seek medical attention immediately if you notice any of the following symptoms:
Severe skin reaction with blistering, widespread scaly skin, pus-filled spots together with fever. This could be a condition called Acute Generalized Exanthematous Pustulosis(AGEP).
Sometimes Morphgesic SR Tablets can aggravate “spasm” (or contraction) of the bile duct (which is attached to the gall bladder) or ureter (which drains urine from the kidneys to the bladder).
These effects can lead to abdominal pain or difficulty in passing water.
If you notice:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Not Known: frequency cannot be estimated from the available data.
Some of these effects are more common if you are mobile than if you are confined to bed.
Drug Withdrawal
When you stop taking morphine sulfate, you may experience drug withdrawal symptoms, which include restlessness, difficulty sleeping, irritability, agitation, anxiety, feeling your heartbeat (palpitations), increased blood pressure, feeling or being sick, diarrhoea, shaking, shivering or sweating.
If you notice any of the following signs whilst taking Morphgesic SR Tablets, it could be a sign that you have become addicted.
If you notice any of these signs, it is important you talk to your prescriber
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25ºC. Store in the original package.
Do not use this medicine after the expiry date, which is stated on the carton after ‘EXP’. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
There are 4 different strengths (10 mg, 30 mg, 60 mg and 100 mg) of Morphgesic SR Tablets.
The active substance is morphine sulfate.
The other ingredients are lactose (except 100 mg tablets), povidone, hydroxyethylcellulose, talc, magnesium stearate, hypromellose (E464), macrogol and industrial methylated spirit 99%.
The different strength tablets also contain the following colourants:
10 mg tablets: Titanium Dioxide (E171), Iron Oxide Yellow (E172) and Iron Oxide Red (E172).
30 mg tablets: Titanium Dioxide (E171), Erythrosine (E127), Indigo Carmine (E132) and Sunset Yellow (E110).
60 mg tablets: Titanium Dioxide (E171) and Sunset Yellow (E110).
100 mg tablets: Titanium Dioxide (E171) and Iron Oxide Black (E172).
10 mg tablets are buff, embossed with 10 on one face and contain 10 mg of the active ingredient morphine sulfate.
30 mg tablets are violet, embossed with 30 on one face and contain 30 mg of the active ingredient morphine sulfate.
60 mg tablets are orange, embossed with 60 on one face and contain 60 mg of the active ingredient morphine sulfate.
100 mg tablets are grey, embossed with 100 on one face and contain 100 mg of the active ingredient morphine sulfate.
Each strength of Morphgesic SR Tablets is available in packs containing 10 or 60 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer:
This leaflet was last revised in October 2023
® Amdipharm is licensed to use the registered trademark.
Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK
+44 (0)208 588 9131
www.advanzpharma.com
+44 (0)208 588 9131
+44 (0)208 588 9273